Global NGS-Based Monitoring and Diagnostic Test Market Growth (Status and Outlook) 2020-2025


Sep, 2020 | Report ID: 150547 | 130 | Technology

According to this study, over the next five years the NGS-Based Monitoring and Diagnostic Test market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in NGS-Based Monitoring and Diagnostic Test business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of NGS-Based Monitoring and Diagnostic Test market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the NGS-Based Monitoring and Diagnostic Test, covering the supply chain analysis, impact assessment to the NGS-Based Monitoring and Diagnostic Test market size growth rate in several scenarios, and the measures to be undertaken by NGS-Based Monitoring and Diagnostic Test companies in response to the COVID-19 epidemic.

Segmentation by product type:

Commercial Assays/Tests

Laboratory Developed Tests

Direct to Consumer Test

Pre-Commercial Tests

Segmentation by Application:

Out-Patient Clinics/General Practitioners

Diagnostic Centers

Hospitals

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/players in the market. The key players covered in this report:

Agilent Technologies, Inc.

Laboratory Corporation of America Holdings

Ancestry.com LLC

Beijing Genomics Institute (BGI)

Cancer Genetics, Inc.

ArcherDX, Inc.

GenePath Dx

CENTOGENE AG

Illumina, Inc.

F. Hoffmann-La Roche Ltd

HTG Molecular Diagnostics, Inc.

Vela Diagnostics Pte. Ltd.

Myriad Genetics, Inc.

Siemens Healthineers, Inc.

Quest Diagnostics Incorporated

Thermo Fisher Scientific Inc.

QIAGEN N.V.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global NGS-Based Monitoring and Diagnostic Test market size by key regions/countries, type and application.

To understand the structure of NGS-Based Monitoring and Diagnostic Test market by identifying its various subsegments.

Focuses on the key global NGS-Based Monitoring and Diagnostic Test players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the NGS-Based Monitoring and Diagnostic Test with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of NGS-Based Monitoring and Diagnostic Test submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global NGS-Based Monitoring and Diagnostic Test Market Size 2021-2025

2.1.2 NGS-Based Monitoring and Diagnostic Test Market Size CAGR by Region

2.2 NGS-Based Monitoring and Diagnostic Test Segment by Type

2.2.1 Commercial Assays/Tests

2.2.2 Laboratory Developed Tests

2.2.3 Direct to Consumer Test

2.2.4 Pre-Commercial Tests

2.3 NGS-Based Monitoring and Diagnostic Test Market Size by Type

2.3.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2021-2025)

2.3.2 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type (2021-2025)

2.4 NGS-Based Monitoring and Diagnostic Test Segment by Application

2.4.1 Out-Patient Clinics/General Practitioners

2.4.2 Diagnostic Centers

2.4.3 Hospitals

2.4.4 Others

2.5 NGS-Based Monitoring and Diagnostic Test Market Size by Application

2.5.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2021-2025)

2.5.2 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Application (2021-2025)

3 NGS-Based Monitoring and Diagnostic Test Key Players

3.1 Date of Key Players Enter into NGS-Based Monitoring and Diagnostic Test

3.2 Key Players NGS-Based Monitoring and Diagnostic Test Product Offered

3.3 Key Players NGS-Based Monitoring and Diagnostic Test Funding/Investment Analysis

3.4 Funding/Investment

3.4.1 Funding/Investment by Regions

3.4.2 Funding/Investment by End-Industry

3.5 Key Players NGS-Based Monitoring and Diagnostic Test Valuation & Market Capitalization

3.6 Key Players Mergers & Acquisitions, Expansion Plans

3.7 Market Ranking

3.8 New Product/Technology Launches

3.9 Partnerships, Agreements, and Collaborations

3.10 Mergers and Acquisitions

4 NGS-Based Monitoring and Diagnostic Test by Regions

4.1 NGS-Based Monitoring and Diagnostic Test Market Size by Regions (2015-2020)

4.2 Americas NGS-Based Monitoring and Diagnostic Test Market Size Growth (2015-2020)

4.3 APAC NGS-Based Monitoring and Diagnostic Test Market Size Growth (2015-2020)

4.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size Growth (2015-2020)

5 Americas

5.1 Americas NGS-Based Monitoring and Diagnostic Test Market Size by Countries (2021-2025)

5.2 Americas NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2025)

5.3 Americas NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2025)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC NGS-Based Monitoring and Diagnostic Test Market Size by Regions

6.2 APAC NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2025)

6.3 APAC NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2025)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe NGS-Based Monitoring and Diagnostic Test by Countries (2021-2025)

7.2 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2025)

7.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2025)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Market Drivers, Challenges and Trends

8.1 Market Drivers and Impact

8.1.1 Growing Demand from Key Regions

8.1.2 Growing Demand from Key Applications and Potential Industries

8.2 Market Challenges and Impact

8.3 Market Trends

8.4 Market Ecosystem and Roles

9 Key Investors in NGS-Based Monitoring and Diagnostic Test

9.1 Company A

9.1.1 Company A Company Details

9.1.2 Company Description

9.1.3 Companies Invested by Company A

9.1.4 Company A Key Development and Market Layout

9.2 Company B

9.2.1 Company B Company Details

9.2.2 Company Description

9.2.3 Companies Invested by Company B

9.2.4 Company B Key Development and Market Layout

9.3 Company C

9.3.1 Company C Company Details

9.3.2 Company Description

9.3.3 Companies Invested by Company C

9.3.4 Company C Key Development and Market Layout

9.4 Company D

9.5 ……

10 Key Players Analysis

10.1 Agilent Technologies, Inc.

10.1.1 Agilent Technologies, Inc. Company Information

10.1.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.1.4 Main Business Overview

10.1.5 Agilent Technologies, Inc. Latest Developments

10.2 Laboratory Corporation of America Holdings

10.2.1 Laboratory Corporation of America Holdings Company Information

10.2.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.2.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.2.4 Main Business Overview

10.2.5 Laboratory Corporation of America Holdings Latest Developments

10.3 Ancestry.com LLC

10.3.1 Ancestry.com LLC Company Information

10.3.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.3.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.3.4 Main Business Overview

10.3.5 Ancestry.com LLC Latest Developments

10.4 Beijing Genomics Institute (BGI)

10.4.1 Beijing Genomics Institute (BGI) Company Information

10.4.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.4.4 Main Business Overview

10.4.5 Beijing Genomics Institute (BGI) Latest Developments

10.5 Cancer Genetics, Inc.

10.5.1 Cancer Genetics, Inc. Company Information

10.5.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.5.4 Main Business Overview

10.5.5 Cancer Genetics, Inc. Latest Developments

10.6 ArcherDX, Inc.

10.6.1 ArcherDX, Inc. Company Information

10.6.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.6.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.6.4 Main Business Overview

10.6.5 ArcherDX, Inc. Latest Developments

10.7 GenePath Dx

10.7.1 GenePath Dx Company Information

10.7.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.7.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.7.4 Main Business Overview

10.7.5 GenePath Dx Latest Developments

10.8 CENTOGENE AG

10.8.1 CENTOGENE AG Company Information

10.8.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.8.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.8.4 Main Business Overview

10.8.5 CENTOGENE AG Latest Developments

10.9 Illumina, Inc.

10.9.1 Illumina, Inc. Company Information

10.9.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.9.4 Main Business Overview

10.9.5 Illumina, Inc. Latest Developments

10.10 F. Hoffmann-La Roche Ltd

10.10.1 F. Hoffmann-La Roche Ltd Company Information

10.10.2 NGS-Based Monitoring and Diagnostic Test Product Offered

10.10.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

10.10.4 Main Business Overview

10.10.5 F. Hoffmann-La Roche Ltd Latest Developments

10.11 HTG Molecular Diagnostics, Inc.

10.12 Vela Diagnostics Pte. Ltd.

10.13 Myriad Genetics, Inc.

10.14 Siemens Healthineers, Inc.

10.15 Quest Diagnostics Incorporated

10.16 Thermo Fisher Scientific Inc.

10.17 QIAGEN N.V.

11 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. NGS-Based Monitoring and Diagnostic Test Market Size CAGR by Region (2021-2025) ($ Millions)

Table 4. Major Players of Commercial Assays/Tests

Table 5. Major Players of Laboratory Developed Tests

Table 6. Major Players of Direct to Consumer Test

Table 7. Major Players of Pre-Commercial Tests

Table 8. Global Market Size by Type (2021-2025) ($ Millions)

Table 9. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2021-2025)

Table 10. Global NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2025) ($ Millions)

Table 11. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2021-2025)

Table 12. Date of Global Key Players Enter into NGS-Based Monitoring and Diagnostic Test Market

Table 13. Global Key Players NGS-Based Monitoring and Diagnostic Test Product Offered

Table 14. Key Players NGS-Based Monitoring and Diagnostic Test Funding/Investment ($ Millions)

Table 15. Funding/Investment by Regions

Table 16. Funding/Investment by End Industry

Table 17. Key Players NGS-Based Monitoring and Diagnostic Test Valuation & Market Capitalization ($ Millions)

Table 18. Key Players Mergers & Acquisitions, Expansion Plans

Table 19. NGS-Based Monitoring and Diagnostic Test New Product/Technology Launches

Table 20. NGS-Based Monitoring and Diagnostic Test Industry Partnerships, Agreements, and Collaborations

Table 21. NGS-Based Monitoring and Diagnostic Test Industry Mergers and Acquisitions

Table 22. Global NGS-Based Monitoring and Diagnostic Test Market Size by Regions 2021-2025 ($ Millions)

Table 23. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Regions 2021-2025

Table 24. Americas NGS-Based Monitoring and Diagnostic Test Market Size by Countries (2021-2025) ($ Millions)

Table 25. Americas NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Countries (2021-2025)

Table 26. Americas NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2025) ($ Millions)

Table 27. Americas NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2021-2025)

Table 28. Americas NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2025) ($ Millions)

Table 29. Americas NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2021-2025)

Table 30. APAC NGS-Based Monitoring and Diagnostic Test Market Size by Regions (2021-2025) ($ Millions)

Table 31. APAC NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Regions (2021-2025)

Table 32. APAC NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2025) ($ Millions)

Table 33. APAC NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2021-2025)

Table 34. APAC NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2025) ($ Millions)

Table 35. APAC NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2021-2025)

Table 36. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Countries (2021-2025) ($ Millions)

Table 37. Europe NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Countries (2021-2025)

Table 38. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2025) ($ Millions)

Table 39. Europe NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2021-2025)

Table 40. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2025) ($ Millions)

Table 41. Europe NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2021-2025)

Table 42. Key and Potential Regions of NGS-Based Monitoring and Diagnostic Test

Table 43. Key Application and Potential Industries of NGS-Based Monitoring and Diagnostic Test

Table 44. Key Challenges of NGS-Based Monitoring and Diagnostic Test

Table 45. Key Trends of NGS-Based Monitoring and Diagnostic Test

Table 46. Company A Company Details

Table 47. Companies Invested by Company A

Table 48. Company A Key Development and Market Layout

Table 49. Company B Company Details

Table 50. Companies Invested by Company B

Table 51. Company B Key Development and Market Layout

Table 52. Company C Company Details

Table 53. Companies Invested by Company C

Table 54. Company C Key Development and Market Layout

Table 55. Company C Company Details

Table 56. Companies Invested by Company C

Table 57. Company C Key Development and Market Layout

Table 58. Agilent Technologies, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 59. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 60. Laboratory Corporation of America Holdings Basic Information, Head Office, Major Market Areas and Its Competitors

Table 61. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 62. Ancestry.com LLC Basic Information, Head Office, Major Market Areas and Its Competitors

Table 63. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 64. Beijing Genomics Institute (BGI) Basic Information, Head Office, Major Market Areas and Its Competitors

Table 65. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 66. Cancer Genetics, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 67. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 68. ArcherDX, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 69. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 70. GenePath Dx Basic Information, Head Office, Major Market Areas and Its Competitors

Table 71. GenePath Dx NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 72. CENTOGENE AG Basic Information, Head Office, Major Market Areas and Its Competitors

Table 73. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 74. Illumina, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 75. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 76. F. Hoffmann-La Roche Ltd Basic Information, Head Office, Major Market Areas and Its Competitors

Table 77. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 78. HTG Molecular Diagnostics, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 79. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 80. Vela Diagnostics Pte. Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 81. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 82. Myriad Genetics, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 83. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 84. Siemens Healthineers, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 85. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 86. Quest Diagnostics Incorporated Basic Information, Head Office, Major Market Areas and Its Competitors

Table 87. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 88. Thermo Fisher Scientific Inc. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 89. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

Table 90. QIAGEN N.V. Basic Information, Head Office, Major Market Areas and Its Competitors

Table 91. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Market Size (2020 VS 2025)

List of Figures

Figure 1. Picture of NGS-Based Monitoring and Diagnostic Test

Figure 2. NGS-Based Monitoring and Diagnostic Test Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate 2021-2025 ($ Millions)

Figure 5. NGS-Based Monitoring and Diagnostic Test Market Size by Region (2020 & 2025) ($ millions)

Figure 6. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2021-2025)

Figure 7. Global Commercial Assays/Tests Market Size Growth Rate

Figure 8. Global Laboratory Developed Tests Market Size Growth Rate

Figure 9. Global Direct to Consumer Test Market Size Growth Rate

Figure 10. Global Pre-Commercial Tests Market Size Growth Rate

Figure 11. NGS-Based Monitoring and Diagnostic Test Consumed in Out-Patient Clinics/General Practitioners

Figure 12. Global NGS-Based Monitoring and Diagnostic Test Market: Out-Patient Clinics/General Practitioners (2021-2025) ($ Millions)

Figure 13. Global Out-Patient Clinics/General Practitioners YoY Growth ($ Millions)

Figure 14. NGS-Based Monitoring and Diagnostic Test Consumed in Diagnostic Centers

Figure 15. Global NGS-Based Monitoring and Diagnostic Test Market: Diagnostic Centers (2021-2025) ($ Millions)

Figure 16. Global Diagnostic Centers YoY Growth ($ Millions)

Figure 17. NGS-Based Monitoring and Diagnostic Test Consumed in Hospitals

Figure 18. Global NGS-Based Monitoring and Diagnostic Test Market: Hospitals (2021-2025) ($ Millions)

Figure 19. Global Hospitals YoY Growth ($ Millions)

Figure 20. NGS-Based Monitoring and Diagnostic Test Consumed in Others

Figure 21. Global NGS-Based Monitoring and Diagnostic Test Market: Others (2021-2025) ($ Millions)

Figure 22. Global Others YoY Growth ($ Millions)

Figure 23. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2021-2025)

Figure 24. Global NGS-Based Monitoring and Diagnostic Test Market Size in Out-Patient Clinics/General Practitioners Growth Rate

Figure 25. Global NGS-Based Monitoring and Diagnostic Test Market Size in Diagnostic Centers Growth Rate

Figure 26. Global NGS-Based Monitoring and Diagnostic Test Market Size in Hospitals Growth Rate

Figure 27. Global NGS-Based Monitoring and Diagnostic Test Market Size in Others Growth Rate

Figure 28. Funding/Investment

Figure 29. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Regions 2021-2025

Figure 30. Americas NGS-Based Monitoring and Diagnostic Test Market Size 2021-2025 ($ Millions)

Figure 31. APAC NGS-Based Monitoring and Diagnostic Test Market Size 2021-2025 ($ Millions)

Figure 32. Europe NGS-Based Monitoring and Diagnostic Test Market Size 2021-2025 ($ Millions)

Figure 33. Americas NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Countries in 2020

Figure 34. Americas NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type in 2020

Figure 35. Americas NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application in 2020

Figure 36. United States NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 37. Canada NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 38. Mexico NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 39. APAC NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Regions in 2020

Figure 40. APAC NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type in 2020

Figure 41. APAC NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application in 2020

Figure 42. China NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 43. Japan NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 44. Korea NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 45. Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 46. India NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 47. Australia NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 48. Europe NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Countries in 2020

Figure 49. Europe NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type in 2020

Figure 50. Europe NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application in 2020

Figure 51. Germany NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 52. France NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 53. UK NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 54. Italy NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Figure 55. Russia NGS-Based Monitoring and Diagnostic Test Market Size Growth 2021-2025 ($ Millions)

Sample Request is not available